Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Small Centers with Big Ventures: Autologous Stem Cell Transplantation Survival Data Asian Pac J Cancer Prev 2019 Apr 29;20(4):987-990

Date

04/30/2019

Pubmed ID

31030464

Pubmed Central ID

PMC6948904

DOI

10.31557/APJCP.2019.20.4.987

Scopus ID

2-s2.0-85065403037

Abstract

We present the first-ever autologous stem cell transplantation (ASCT) outcome data from a secondary-care

healthcare facility. Albeit exact details of patient and disease characteristics and co-morbidity scores for all patients

are not available, the engraftment and survival data is very similar to those published from large tertiary-care cancer

centres, both regionally and internationally. Transplant Related Mortality (TRM) of 3.1% is within the expected range

and includes a patient who died of acute drug reaction (ADR) during conditioning chemotherapy, prior to the ASCT.

Furthermore, cyclophosphamide mobilization chemotherapy is given in the outpatient setting. This study is important in

terms of healthcare resource optimization as well as patients’ convenience and highlights that ASCT can be performed

in a safe and effective manner with comparable survival rates even at a DGH, provided the centre stays abreast with

the recent developments and can offer its patients with standard of care treatment of the era.

Author List

Abid MB, Mughal M, Babbra R, Abid MA, Blesing N, Anwer S

Author

Muhammad Bilal Abid MD Assistant Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Aged
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation
Hospitals, Low-Volume
Humans
Lymphoma
Male
Middle Aged
Prognosis
Retrospective Studies
Survival Rate
Transplantation, Autologous